Cargando…
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in December 2019, more than 269 million cases and over 5.3 million deaths have been confirmed worldwide. COVID-19 is a highly infectious pneumonia, caused by a novel virus called severe acute respiratory syndrome coron...
Autores principales: | Li, Xianghui, Zhang, Yabo, He, Libing, Si, Jiangzhe, Qiu, Shuai, He, Yuhua, Wei, Jiacun, Wang, Zhili, Xie, Longxiang, Li, Yanzhang, Teng, Tieshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935217/ https://www.ncbi.nlm.nih.gov/pubmed/35342348 http://dx.doi.org/10.7150/ijbs.66369 |
Ejemplares similares
-
A combination therapy of Phages and Antibiotics: Two is better than one
por: Li, Xianghui, et al.
Publicado: (2021) -
Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics
por: Li, Xianghui, et al.
Publicado: (2021) -
Hydrogen Sulfide and Its Donors: Keys to Unlock the Chains of Nonalcoholic Fatty Liver Disease
por: Li, Xianghui, et al.
Publicado: (2022) -
Identification and Characterization of pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18
por: Teng, Tieshan, et al.
Publicado: (2020) -
Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)